Deerfield Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DKCM
WAM
AGM
TCM
CS
Deerfield Management's STLNW Position: Q1 2026 in Review
Deerfield Management held its Starling Oncology, Inc. Warrant (STLNW) position steady in Q1 2026 at 1,250,000 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #78.
Deerfield Management first reported a position in STLNW in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.16M in Q2 2021. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.
- Deerfield Management held 1,250,000 shares of Starling Oncology, Inc. Warrant worth $54.8K as of Q1 2026.
- Deerfield Management left its Starling Oncology, Inc. Warrant share count unchanged in Q1 2026.
- Starling Oncology, Inc. Warrant made up ﹤0.01% of Deerfield Management's portfolio in Q1 2026, its #78 holding.
- Deerfield Management first reported a position in Starling Oncology, Inc. Warrant in Q1 2021 and has held it in 21 quarters since.
- Deerfield Management's Starling Oncology, Inc. Warrant position peaked at $2.16M in Q2 2021.
- 11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.
Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.